TAMPA, Fla. – The National Cancer Institute has awarded a $2.2 million grant to Moffitt Cancer Center researcher Kathleen Egan, Ph.D., to develop a postdoctoral training program in molecular and genetic epidemiology.
“It is meant to train the next generation of population scientists,” said Egan, a senior member of the Risk Assessment, Detection & Intervention (RADI) program. Postdoctoral fellows will study genetic and molecular contributions to cancer risk and cancer outcomes in populations.
The training program will provide a specialized curriculum to prepare academic researchers to integrate the latest technologies and full spectrum of outcomes (from risk to survival) in molecular and genetic epidemiology. There is a shortage of scientists with specialized training in these areas. The NCI R25 grant will train eight postdoctoral fellows over five years.
The training grant is the first R25 for the RADI program. The award adds to Moffitt’s training grant portfolio, which includes the R25 grant for Paul Jacobsen, Ph.D., in Health Outcomes & Behavior; the T-32 grant for Julie Djeu, Ph.D., in Immunology; the NCI-funded Project LINK program for Cathy Meade, Ph.D., R.N., F.A.A.N.; and many minority training supplements.
About Moffitt Cancer Center Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center – a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 14 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.